BACKGROUND: Antibiotic use by one individual may affect selection for antimicrobial resistance in close contacts. Here we evaluated whether oral antibiotic treatment of one child within a household affected the gut resistome of an untreated cohabiting child. METHODS:Households with at least two children <5 y of age were randomized in a 1:1 fashion to a 5d course of azithromycin or placebo. To evaluate indirect effects of azithromycin treatment on the gut resistome, we randomly assigned one child in the house to azithromycin and one to placebo. In placebo households, each child received placebo. We performed DNA sequencing of rectal swabs collected 5 d after the last antibiotic dose. We estimated risk ratios for the presence of genetic resistance determinants at the class level using modified Poisson models for children in azithromycin households compared with placebo households and assessed the composition of the resistome using permutational analysis of variance (PERMANOVA). RESULTS: Of 58 children (n = 30 azithromycin households, n = 28 placebo households) with post-treatment rectal swabs, genetic resistance determinants were common but there was no significant difference at the class (p = 0.54 for macrolides) or gene (p = 0.94 for structure by PERMANOVA, p = 0.94 for diversity) level between untreated children in azithromycin households compared with placebo households. CONCLUSIONS: The results are encouraging that one child's antibiotic use may not influence the resistome of another child. Trial registration: ClinicalTrials.gov NCT03187834.
RCT Entities:
BACKGROUND: Antibiotic use by one individual may affect selection for antimicrobial resistance in close contacts. Here we evaluated whether oral antibiotic treatment of one child within a household affected the gut resistome of an untreated cohabiting child. METHODS: Households with at least two children <5 y of age were randomized in a 1:1 fashion to a 5d course of azithromycin or placebo. To evaluate indirect effects of azithromycin treatment on the gut resistome, we randomly assigned one child in the house to azithromycin and one to placebo. In placebo households, each child received placebo. We performed DNA sequencing of rectal swabs collected 5 d after the last antibiotic dose. We estimated risk ratios for the presence of genetic resistance determinants at the class level using modified Poisson models for children in azithromycin households compared with placebo households and assessed the composition of the resistome using permutational analysis of variance (PERMANOVA). RESULTS: Of 58 children (n = 30 azithromycin households, n = 28 placebo households) with post-treatment rectal swabs, genetic resistance determinants were common but there was no significant difference at the class (p = 0.54 for macrolides) or gene (p = 0.94 for structure by PERMANOVA, p = 0.94 for diversity) level between untreated children in azithromycin households compared with placebo households. CONCLUSIONS: The results are encouraging that one child's antibiotic use may not influence the resistome of another child. Trial registration: ClinicalTrials.gov NCT03187834.
Authors: Catherine E Oldenburg; Armin Hinterwirth; Ali Sié; Boubacar Coulibaly; Lucienne Ouermi; Clarisse Dah; Charlemagne Tapsoba; Susie L Cummings; Lina Zhong; Cindi Chen; Samarpita Sarkar; Till Bärnighausen; Thomas M Lietman; Jeremy D Keenan; Thuy Doan Journal: Clin Infect Dis Date: 2020-01-16 Impact factor: 9.079
Authors: Ali Sié; Boubacar Coulibaly; Sawadogo Adama; Lucienne Ouermi; Clarisse Dah; Charlemagne Tapsoba; Till Bärnighausen; John Daniel Kelly; Thuy Doan; Thomas M Lietman; Jeremy D Keenan; Catherine E Oldenburg Journal: Am J Trop Med Hyg Date: 2019-05 Impact factor: 2.345
Authors: T Doan; A Hinterwirth; L Worden; A M Arzika; R Maliki; A Abdou; S Kane; L Zhong; S L Cummings; S Sakar; C Chen; C Cook; E Lebas; E D Chow; I Nachamkin; T C Porco; J D Keenan; T M Lietman Journal: Nat Med Date: 2019-08-12 Impact factor: 53.440
Authors: Elizabeth T Rogawski; James A Platts-Mills; Jessica C Seidman; Sushil John; Mustafa Mahfuz; Manjeswori Ulak; Sanjaya K Shrestha; Sajid Bashir Soofi; Pablo Penataro Yori; Estomih Mduma; Erling Svensen; Tahmeed Ahmed; Aldo Am Lima; Zulfiqar A Bhutta; Margaret N Kosek; Dennis R Lang; Michael Gottlieb; Anita Km Zaidi; Gagandeep Kang; Pascal O Bessong; Eric R Houpt; Richard L Guerrant Journal: Bull World Health Organ Date: 2016-11-03 Impact factor: 9.408
Authors: Catherine E Oldenburg; Ali Sié; Boubacar Coulibaly; Lucienne Ouermi; Clarisse Dah; Charlemagne Tapsoba; Till Bärnighausen; Elodie Lebas; Ahmed M Arzika; Susie Cummings; Lina Zhong; Thomas M Lietman; Jeremy D Keenan; Thuy Doan Journal: Open Forum Infect Dis Date: 2019-02-06 Impact factor: 3.835
Authors: Thuy Doan; Ahmed M Arzika; Armin Hinterwirth; Ramatou Maliki; Lina Zhong; Susie Cummings; Samarpita Sarkar; Cindi Chen; Travis C Porco; Jeremy D Keenan; Thomas M Lietman Journal: N Engl J Med Date: 2019-06-06 Impact factor: 91.245
Authors: Jeremy D Keenan; Robin L Bailey; Sheila K West; Ahmed M Arzika; John Hart; Jerusha Weaver; Khumbo Kalua; Zakayo Mrango; Kathryn J Ray; Catherine Cook; Elodie Lebas; Kieran S O'Brien; Paul M Emerson; Travis C Porco; Thomas M Lietman Journal: N Engl J Med Date: 2018-04-26 Impact factor: 91.245